Home - Products - Tyrosine Kinase - c-RET - 4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid

4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid

CAS No. 144059-86-9

4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid( —— )

Catalog No. M18018 CAS No. 144059-86-9

4-Methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylic acid is a metabolite of GW 501516.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 60 In Stock
25MG 106 In Stock
50MG 159 In Stock
100MG 239 In Stock
200MG 357 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylic acid is a metabolite of GW 501516.
  • Description
    4-Methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylic acid is a metabolite of GW 501516.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    c-RET
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    144059-86-9
  • Formula Weight
    287.26
  • Molecular Formula
    C12H8F3NO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(SC(=N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Compound TPX-0046

    Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer.

  • Vepafestinib

    Vepafestinib is a RET inhibitor with potential antineoplastic activity.

  • Enbezotinib

    Enbezotinib is an inhibitor of RET autophosphorylation and can be used in cancer research.